Slingshot members are tracking this event:
Revance's (RVNC) RT002 Superior to Allergan's (AGN) BOTOX in Phase 2 Study Evaluating Treatment of Frown Lines
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Oct 29, 2015
Don’t see a project related to the catalyst you care about?
Related Keywords Rt002, Botox, Dysport, Phase 2, Treatment Of Frown Lines, Glabellar Lines